MJN110

CAS: 1438416-21-7

Ref. 3D-NHC41621

Produktinformation

• Name: MJN110
• Synonyme: 1-Piperazinecarboxylic acid, 4-[bis(4-chlorophenyl)methyl]-, 2,5-dioxo-1-pyrrolidinyl ester, 2,5-Dioxopyrrolidin-1-yl 4-[bis(4-chlorophenyl)methyl]piperazine-1-carboxylate, MJN 110

Beschreibung

MJN110 is a novel drug that inhibits the activity of fatty acid amide hydrolase (FAAH), an enzyme that breaks down anandamide, one of the body's natural endocannabinoids. MJN110 has been shown to have potent antinociceptive and anti-inflammatory effects in animal models. It also has been shown to have beneficial effects on chronic viral hepatitis, as well as other diseases such as type 2 diabetes, neuropathic pain, and Parkinson's disease. MJN110 may be used as an analgesic, anti-inflammatory agent, or agent for treating chronic viral hepatitis.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 462.33 g/mol
• Formel: C₂₂H₂₁Cl₂N₃O₄
• Reinheit: Min. 95%